Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 8
Submit an article Journal homepage
122
Views
17
CrossRef citations to date
0
Altmetric
Letter to the Editor

Fulminant, but reversible interstitial pneumonitis associated with imatinib mesylate

Jen-Tsun Lin Division of Hematology and Oncology, Department of Medicine
,
Kun-Tu Yeh Department of Pathology
,
Hsin-Yuan Fang Department of Thoracic Surgery, Chang Hua Christian Medical Center, Chang Hua, Taiwan
&
Cheng-Shyong Chang Division of Hematology and Oncology, Department of MedicineCorrespondence[email protected]
, MD
Pages 1693-1695 | Received 25 Aug 2005, Accepted 31 Jan 2006, Published online: 01 Jul 2009

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Li Li, Henry Mok, Pavan Jhaveri, Mark D Bonnen, Andrew G Sikora, N. Tony Eissa, Ritsuko U Komaki & Yohannes T Ghebre. (2018) Anticancer therapy and lung injury: molecular mechanisms. Expert Review of Anticancer Therapy 18:10, pages 1041-1057.
Read now
Christopher Donatelli, Daych Chongnarungsin & Rendell Ashton. (2014) Acute respiratory failure from nilotinib-associated diffuse alveolar hemorrhage. Leukemia & Lymphoma 55:10, pages 2408-2409.
Read now

Articles from other publishers (15)

Manuel Ramos-Casals, Alejandra Flores-Chávez, Pilar Brito-Zerón, Olivier Lambotte & Xavier Mariette. (2022) Immune-related adverse events of cancer immunotherapies targeting kinases. Pharmacology & Therapeutics 237, pages 108250.
Crossref
Faten Kallel, Olfa Kassar, Imen Maaloul, Maha Charfi, Kamilia Ksouda & Moez Elloumi. (2020) Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia. Journal of Oncology Pharmacy Practice 27:7, pages 1762-1765.
Crossref
Pradnya D. Patil & Tanmay S. Panchabhai. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities 133 146 .
Sharon Ovnat Tamir, Dafna Gershnabel Milk, Yehudah Roth, Udi Cinamon, Asher Winder, Ronen Brenner, Ariel Katz & Tal Marom. (2016) Laryngeal Side Effects of Tyrosine Kinase Inhibitors. Journal of Voice 30:5, pages 606-610.
Crossref
Megan M. Dulohery, Fabien Maldonado & Andrew H. Limper. 2016. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine 1275 1294.e17 .
Neelesh Sharma, Ellen Kim & Mitchell Machtay. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 845 857.e4 .
Se-Il Go, Won Sup Lee, Gyeong-Won Lee, Jung Hun Kang, Myung Hee Kang, Jeong-Hee Lee & Hoon-Gu Kim. (2013) Nilotinib-induced interstitial lung disease. International Journal of Hematology 98:3, pages 361-365.
Crossref
Ai-Ping Chua, Jose Fernando Santacruz & Thomas R. Gildea. 2011. Supportive Oncology. Supportive Oncology 309 325 .
François Vincent. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies 741 749 .
Edward Rosenow IIIAlbert Polito. 2010. Drug-induced and Iatrogenic Respiratory Disease. Drug-induced and Iatrogenic Respiratory Disease.
K.Y. Yoneda & C.E. Cross. 2010. Comprehensive Toxicology. Comprehensive Toxicology 477 510 .
Bobbak Vahid & Paul E. Marik. (2008) Pulmonary Complications of Novel Antineoplastic Agents for Hematologic Malignancies. Clinical Pulmonary Medicine 15:2, pages 71-80.
Crossref
Bobbak Vahid & Paul E. Marik. (2008) Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors. Chest 133:2, pages 528-538.
Crossref
Mitchell Machtay. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 969 981 .
Ehab Atallah, Hagop Kantarjian & Jorge Cortes. (2007) Emerging Safety Issues with Imatinib and Other Abl Tyrosine Kinase Inhibitors. Clinical Lymphoma and Myeloma 7, pages S105-S112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.